Xiao-Ping Peng
Impact in
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis
- Biotechnology top 5%
- Marine Sponges and Natural Products
Papers in
- Pharmacology 33
- Microbial Natural Products and Biosynthesis 33
-
- PI3K/AKT/mTOR signaling in cancer 3
- Ubiquitin and proteasome pathways 1
- Inflammasome and immune disorders 1
- Co-authors
- Weiming Zhu (7 shared papers)Gang Li (29 shared papers)Peipei Liu (4 shared papers)Hong-Xiang Lou (26 shared papers)Kui Hong (2 shared papers)Xia Yin (2 shared papers)Xin Wang (1 shared paper)Yi Wang (1 shared paper)
In The Last Decade
Xiao-Ping Peng
41 papers receiving 986 citations
Peers
Comparison fields: 5 of 67
- Pharmacology 474
- Biotechnology 72
- Cell Biology 106
- Molecular Biology 245
- Cancer Research 28
Countries citing papers authored by Xiao-Ping Peng
This map shows the geographic impact of Xiao-Ping Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Ping Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Ping Peng more than expected).
Fields of papers citing papers by Xiao-Ping Peng
This network shows the impact of papers produced by Xiao-Ping Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Ping Peng. The network helps show where Xiao-Ping Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao-Ping Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 148 | |
| 2 | 2018 | 106 | |
| 3 | 2009 | 100 | |
| 4 | 2009 | 79 | |
| 5 | 2011 | 67 | |
| 6 | 2018 | 55 | |
| 7 | 2011 | 45 | |
| 8 | 2019 | 44 | |
| 9 | 2022 | 36 | |
| 10 | 2019 | 26 | |
| 11 | 2017 | 23 | |
| 12 | 2019 | 23 | |
| 13 | 2019 | 23 | |
| 14 | 2019 | 19 | |
| 15 | 2021 | 18 | |
| 16 | 2019 | 17 | |
| 17 | 2021 | 15 | |
| 18 | 2023 | 15 | |
| 19 | 2017 | 14 | |
| 20 | 2024 | 14 |
About Xiao-Ping Peng
Xiao-Ping Peng is a scholar working on Pharmacology, Molecular Biology, Biotechnology, Cell Biology and Inorganic Chemistry, having authored 45 papers that have together received 1k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (33 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Marine Sponges and Natural Products (1 paper), Ubiquitin and proteasome pathways (1 paper), Antifungal resistance and susceptibility (1 paper), Plant Pathogenic Bacteria Studies (1 paper), Inflammasome and immune disorders (1 paper) and Crystal structures of chemical compounds (1 paper). The work is most often cited by research in Pharmacology (474 citations), Biotechnology (72 citations), Cell Biology (106 citations), Molecular Biology (245 citations) and Cancer Research (28 citations). Xiao-Ping Peng has collaborated with scholars based in China, Slovakia and Japan. Frequent co-authors include Weiming Zhu, Gang Li, Peipei Liu, Hong-Xiang Lou, Kui Hong, Xia Yin, Xin Wang, Yi Wang, Jinkai Zheng and Yi Wang. Their work appears in journals such as Journal of Natural Products, Organic Letters, Marine Drugs, Archives of Pharmacal Research and Steroids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.